PHIO:NASDAQ, Phio Pharmaceuticals Corp.

PHIO stock overview

Phio Pharmaceuticals Corp. (PHIO:NASDAQ) closed at $0.852 on October 23, 2026, down 2.30% on the day. The stock trades 79.7% below its 52-week high of $4.19 and 4.8% above its 52-week low of $0.813. Over the past year, it lost 59.8%. Phio Pharmaceuticals Corp. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$0.852
Day change
-2.30%
Volume
28,713
Average volume
132,512
Market cap
9M+
52-week range
$0.813 – $4.19
50-day average
$1.03
200-day average
$1.10

Price action over the past year

In 252 trading sessions since October 23, 2025, PHIO closed higher on 108 days (43%). Its best day was February 13, 2026 (+35.25%) and its worst was February 18, 2026 (-21.09%). The stock moved 10% or more in a single session 11 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

PHIO news

About Phio Pharmaceuticals Corp.

RXi Pharmaceuticals Corp is principally engaged in developing therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs.

Similar stocks

Find more stocks like PHIO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.